Darunavir/ritonavir monotherapy in clinical practice

被引：1
|
作者：
Parienti, Jean-Jacques [1 ,2 ,3 ]
机构：
[1] Caen Cote de Nacre Univ Hosp, Dept Infect Dis & Clin Res & Biostat, Caen, France
[2] Univ Paris 06, Paris, France
[3] INSERM, UMR S 707, Paris, France
来源：
AIDS | 2011年 / 25卷 / 01期
关键词：
INDINAVIR;
D O I：
10.1097/QAD.0b013e3283405d2c
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：119 / 119
页数：1
相关论文
共 50 条
  • [1] Virological efficacy of darunavir/ritonavir monotherapy in clinical practice
    Brown, G.
    Scott, C.
    Teague, A.
    Bower, M.
    Gazzard, B.
    Nelson, M.
    HIV MEDICINE, 2010, 11 : 24 - 24
  • [2] Monotherapy with darunavir/ritonavir is effective and safe in clinical practice
    Pasquau, Juan
    Lopez-Cortes, Luis
    Isabel Mayorga, Maria
    Viciana, Pompeyo
    del Mar Arenas, Maria
    Jose Rios, Maria
    Hernandez-Quero, Jose
    Castano, Manuel
    Dolores Merino, Maria
    Marquez, Manuel
    Vergara, Antonio
    Terron, Alberto
    Tellez, Francisco
    Hidalgo-Tenorio, Carmen
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2014, 17 : 196 - 197
  • [3] Simplification of Antiretroviral Treatment from Darunavir/Ritonavir Monotherapy to Darunavir/Cobicistat Monotherapy: Effectiveness and Safety in Routine Clinical Practice
    Santos, Jose R.
    Curran, Adrian
    Navarro-Mercade, Jordi
    Ampuero, Mario F.
    Pelaez, Pablo
    Perez-Alvarez, Nuria
    Clotet, Bonaventura
    Paredes, Roger
    Molto, Jose
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2019, 35 (06) : 513 - 518
  • [4] Antiretroviral Simplification with Darunavir/Ritonavir Monotherapy in Routine Clinical Practice: Safety, Effectiveness, and Impact on Lipid Profile
    Santos, Jose R.
    Molto, Jose
    Llibre, Josep M.
    Negredo, Eugenia
    Bravo, Isabel
    Ornelas, Arelly
    Clotet, Bonaventura
    Paredes, Roger
    PLOS ONE, 2012, 7 (05):
  • [5] Outcomes of protease inhibitor Darunavir/Ritonavir (DRV/r) monotherapy in a clinical setting
    Castles, R.
    Pacho, C.
    Swan, J.
    Sonecha, S.
    Nelson, M.
    HIV MEDICINE, 2012, 13 : 70 - 70
  • [6] SIMPLIFICATION OF THE ANTIRETROVIRAL TREATMENT WITH DARUNAVIR BOOSTED WITH RITONAVIR IN MONOTHERAPY
    Rivas Luis, Gonzalez
    Gomez Ernesto, Sanchez
    del Moral Raquel, Sanchez
    Saiz Salvador, Grutzmancher
    de la Llave Emilio, Pujol
    ATENCION FARMACEUTICA, 2011, 13 (06): : 370 - +
  • [7] Short Communication: Efficacy and Safety of Treatment Simplification to Lopinavir/Ritonavir or Darunavir/Ritonavir Monotherapy: A Randomized Clinical Trial
    Santos, Jose R.
    Llibre, Josep M.
    Bravo, Isabel
    Garcia-Rosado, Dacil
    Paz Canadas, Mari
    Perez-Alvarez, Nuria
    Paredes, Roger
    Clotet, Bonaventura
    Molto, Jose
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2016, 32 (05) : 452 - 455
  • [8] Budget impact analysis of switch to darunavir/ritonavir monotherapy in Greece
    Lazanas, M.
    Hill, A.
    Sawyer, A.
    Paparouni, K.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2012, 15 : 69 - 69
  • [9] Darunavir/ritonavir (DRV/r) monotherapy durability and tolerance study
    Dean, S.
    Longley, J.
    Nelson, M.
    Bower, M.
    HIV MEDICINE, 2014, 15 : 118 - 118
  • [10] Central Nervous System Penetration and Effectiveness of Darunavir/Ritonavir Monotherapy
    Perez Valero, Ignacio
    Gonzalez-Baeza, Alicia
    Montes Ramirez, Maria Luisa
    AIDS REVIEWS, 2014, 16 (02) : 101 - 108
12345